3,5-diamino-6-chloro-N-[8-(4-cyanobenzoyl)-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-(4-hydroxybenzoyl)-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-(2-methylpropanoyl)-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-(pyridine-3-carbonyl)-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-(pyrimidine-5-carbonyl)-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;methyl 4-[2-[(3,5-diamino-6-chloropyrazine-2-carbonyl)amino]-1,3,8-triazaspiro[4.5]dec-2-ene-8-carbonyl]benzoate
C111H126Cl6N52O15 — CID 158866093
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3,5-diamino-6-chloro-N-[8-(4-cyanobenzoyl)-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-(4-hydroxybenzoyl)-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-(2-methylpropanoyl)-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-(pyridine-3-carbonyl)-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-(pyrimidine-5-carbonyl)-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;methyl 4-[2-[(3,5-diamino-6-chloropyrazine-2-carbonyl)amino]-1,3,8-triazaspiro[4.5]dec-2-ene-8-carbonyl]benzoate
3,5-diamino-6-chloro-N-[8-(4-cyanobenzoyl)-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-(4-hydroxybenzoyl)-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-(2-methylpropanoyl)-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-(pyridine-3-carbonyl)-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-(pyrimidine-5-carbonyl)-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;methyl 4-[2-[(3,5-diamino-6-chloropyrazine-2-carbonyl)amino]-1,3,8-triazaspiro[4.5]dec-2-ene-8-carbonyl]benzoate (PubChem CID 158866093) has the molecular formula C111H126Cl6N52O15 and a molecular weight of 2641.30 g/mol. Its IUPAC name is 3,5-diamino-6-chloro-N-[8-(4-cyanobenzoyl)-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-(4-hydroxybenzoyl)-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-(2-methylpropanoyl)-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-(pyridine-3-carbonyl)-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-(pyrimidine-5-carbonyl)-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;methyl 4-[2-[(3,5-diamino-6-chloropyrazine-2-carbonyl)amino]-1,3,8-triazaspiro[4.5]dec-2-ene-8-carbonyl]benzoate.
Molecular Properties
| Compound Name | 3,5-diamino-6-chloro-N-[8-(4-cyanobenzoyl)-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-(4-hydroxybenzoyl)-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-(2-methylpropanoyl)-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-(pyridine-3-carbonyl)-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-(pyrimidine-5-carbonyl)-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;methyl 4-[2-[(3,5-diamino-6-chloropyrazine-2-carbonyl)amino]-1,3,8-triazaspiro[4.5]dec-2-ene-8-carbonyl]benzoate |
|---|---|
| PubChem CID | 158866093 |
| Molecular Formula | C111H126Cl6N52O15 |
| Molecular Weight | 2641.30 g/mol |
| Exact Mass | 2636.88 |
| IUPAC Name | 3,5-diamino-6-chloro-N-[8-(4-cyanobenzoyl)-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-(4-hydroxybenzoyl)-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-(2-methylpropanoyl)-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-(pyridine-3-carbonyl)-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-(pyrimidine-5-carbonyl)-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;methyl 4-[2-[(3,5-diamino-6-chloropyrazine-2-carbonyl)amino]-1,3,8-triazaspiro[4.5]dec-2-ene-8-carbonyl]benzoate |
| SMILES | CC(C)C(=O)N1CCC2(CC1)CN=C(NC(=O)c1nc(Cl)c(N)nc1N)N2.COC(=O)c1ccc(C(=O)N2CCC3(CC2)CN=C(NC(=O)c2nc(Cl)c(N)nc2N)N3)cc1.N#Cc1ccc(C(=O)N2CCC3(CC2)CN=C(NC(=O)c2nc(Cl)c(N)nc2N)N3)cc1.Nc1nc(N)c(C(=O)NC2=NCC3(CCN(C(=O)c4ccc(O)cc4)CC3)N2)nc1Cl.Nc1nc(N)c(C(=O)NC2=NCC3(CCN(C(=O)c4cccnc4)CC3)N2)nc1Cl.Nc1nc(N)c(C(=O)NC2=NCC3(CCN(C(=O)c4cncnc4)CC3)N2)nc1Cl |
| InChI | InChI=1S/C21H23ClN8O4.C20H20ClN9O2.C19H21ClN8O3.C18H20ClN9O2.C17H19ClN10O2.C16H23ClN8O2/c1-34-19(33)12-4-2-11(3-5-12)18(32)30-8-6-21(7-9-30)10-25-20(29-21)28-17(31)13-15(23)27-16(24)14(22)26-13;21-14-16(24)27-15(23)13(26-14)17(31)28-19-25-10-20(29-19)5-7-30(8-6-20)18(32)12-3-1-11(9-22)2-4-12;20-13-15(22)25-14(21)12(24-13)16(30)26-18-23-9-19(27-18)5-7-28(8-6-19)17(31)10-1-3-11(29)4-2-10;19-12-14(21)25-13(20)11(24-12)15(29)26-17-23-9-18(27-17)3-6-28(7-4-18)16(30)10-2-1-5-22-8-10;18-11-13(20)25-12(19)10(24-11)14(29)26-16-23-7-17(27-16)1-3-28(4-2-17)15(30)9-5-21-8-22-6-9;1-8(2)14(27)25-5-3-16(4-6-25)7-20-15(24-16)23-13(26)9-11(18)22-12(19)10(17)21-9/h2-5H,6-10H2,1H3,(H4,23,24,27)(H2,25,28,29,31);1-4H,5-8,10H2,(H4,23,24,27)(H2,25,28,29,31);1-4,29H,5-9H2,(H4,21,22,25)(H2,23,26,27,30);1-2,5,8H,3-4,6-7,9H2,(H4,20,21,25)(H2,23,26,27,29);5-6,8H,1-4,7H2,(H4,19,20,25)(H2,23,26,27,29);8H,3-7H2,1-2H3,(H4,18,19,22)(H2,20,23,24,26) |
| InChIKey | JBGDHJKDEBPUDH-UHFFFAOYSA-N |
| XLogP | 0.84 |
| TPSA | 1018.71 Ų |
| H-Bond Donors | 25 |
| H-Bond Acceptors | 55 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 184 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2641.30 |
| LogP ≤ 5 | 0.84 |
| H-Bond Donors ≤ 5 | 25 |
| H-Bond Acceptors ≤ 10 | 55 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158866093 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.